Business News


Ovascience-121914.jpgShares of OvaScience Inc. (OVAS) have had a strong run in 2014, rising over 370 percent year-to-date. And that's indeed a very impressive return delivered by the fertility treatment company, which suffered a setback last year when it had to suspend a U.S. trial of its flagship fertility treatment due to regulatory concerns raised by the FDA.
More
Ovascience-121914.jpg

OVAS Delivers As Promised...



Shares of OvaScience Inc. (OVAS) have had a strong run in 2014, rising over 370 percent year-to-date. And that's indeed a very impressive return delivered by the fertility treatment company, which suffered a setback last year when it had to suspend a U.S. trial of its flagship fertility treatment due to regulatory concerns raised by the FDA.
More

Latest News

Nordex Order Intake Up By Around 36% To 112.8 Megawatts

Globo Bags Mobile Solutions Contract From Milton Keynes Council

Bristol Water Names Tim Tutton Non- Executive Director

Alent Reaches Settlement With Moses Lake Industries

More

Nike-121914.jpg

Interesting Stocks To Watch: Dec 19


Here is a list of interesting stocks to watch on December 19. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed below and many more have been researched already, and...
More

Iceland Dec CPI Up 0.3% On Month Vs 0.5% Fall In Nov

Iceland Dec CPI Up 0.8% On Year Vs 1% Rise In Nov

More

Scania Says It Is Continuing To Invest In Sweden


Metso To Divest Tampere Foundry To A Finnish Company TEVO

Wolters Kluwer To Acquire SBS Software GmbH

More

After-market Movers For Dec. 18 (RHT, CTAS, NQ, NKE)


Shares of Red Hat, Inc. (RHT) surged more than 9% in after hours trading after the world's largest seller of Linux software reported forecast-beating third quarter results. Cintas Corp (CTAS) shares rose more than 6% in extended hours trading after the corporate uniform supplier reported better than...
More

Juno Therapeutics Prices IPO Above Range


Juno Therapeutics Inc, a biopharmaceuticals company, on Thursday priced its initial public offering of 11 million common shares at $24.00 each, above the expected range of $21 to $23 per share. Juno has granted the underwriters a 30-day option to purchase up to an additional abou 1.7 million shares...
More

Pier 1 Imports Q3 15 Earnings Conference Call At 4:30 PM ET


Pier 1 Imports Inc. (PIR) will host a conference call at 4:30 PM ET on December 18, 2014, to discuss Q3 15 earnings results. To access the live webcast log on to www.pier1.com To listen to the call, dial 1-800-498-7872 (US) or 1-706-643-0435 (International) with conference ID number 88750368. For...
More